Introduction: Dysmenorrhoea is defined as a severe, painful cramping sensation in the lower abdomen occurring just before or during menstruation. The term primary dysmenorrhoea refers to the pain with no obvious pelvic pathology. It is a common condition, which occurs in 52%, 72% or even 90% of women. It is responsible for the highest degree of absenteeism resulting in loss of work hours and economic loss. The aim of the study is to observe the efficacy of Qurs Kafoor, a compound unani formulation in alleviating Usre Tams ibtedayi (primary dysmenorrhoea) Methodology: Ten patients with regular and painful cycles were observed. USG __ampersandsignndash; pelvis was done to exclude pelvic pathology. Menstrual cramps were rated on a four point scale of dysmenorrhoea, from 0 to 3 depending on the severity. Treatment was given a day prior to the expected date of period until pain persists for 2 consecutive cycles. Reduction in four point scale score is the main outcome measure. Results were considered significant with p __ampersandsignlt; 0.05. Results: Qurs Kafoor showed a significant reduction in four point scale score. In 6 (60%) out of 10 patients four point scale score was reduced to 0, in remaining 4(40%) the four point scale score was reduced to 1. The results were statistically significant. Conclusion: Qurs Kafoor has shown to be effective in the management of primary dysmenorrhoea as assessed by four points scale.